BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA, Zignego AL. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis. 2007;39 Suppl 1:S13-S21. [PMID: 17936215 DOI: 10.1016/s1590-8658(07)80005-3] [Cited by in Crossref: 72] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Calvaruso V, Craxì A. Immunological alterations in hepatitis C virus infection. World J Gastroenterol 2013; 19(47): 8916-8923 [PMID: 24379616 DOI: 10.3748/wjg.v19.i47.8916] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
2 Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis. 2008;3:25. [PMID: 18796155 DOI: 10.1186/1750-1172-3-25] [Cited by in Crossref: 158] [Cited by in F6Publishing: 104] [Article Influence: 11.3] [Reference Citation Analysis]
3 Ferri C, Sebastiani M, Giuggioli D, Colaci M, Fallahi P, Piluso A, Antonelli A, Zignego AL. Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin’s lymphoma, and cancer. World J Hepatol 2015; 7(3): 327-343 [PMID: 25848462 DOI: 10.4254/wjh.v7.i3.327] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 11.6] [Reference Citation Analysis]
4 Colaci M, Malatino L, Antonelli A, Fallahi P, Giuggioli D, Ferri C. Endocrine disorders associated with hepatitis C virus chronic infection. Rev Endocr Metab Disord 2018;19:397-403. [PMID: 30499080 DOI: 10.1007/s11154-018-9475-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Bunchorntavakul C, Mitrani R, Reddy KR. Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road? J Clin Exp Hepatol. 2018;8:81-94. [PMID: 29743799 DOI: 10.1016/j.jceh.2017.11.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chou JW, Lin YL, Cheng KS, Wu PY, Reanne Ju T. Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature. Intern Med 2017;56:1831-7. [PMID: 28717078 DOI: 10.2169/internalmedicine.56.7595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Ferrari SM, Fallahi P, Antonelli A, Benvenga S. Environmental Issues in Thyroid Diseases. Front Endocrinol (Lausanne) 2017;8:50. [PMID: 28373861 DOI: 10.3389/fendo.2017.00050] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
8 Fallahi P, Ferrari SM, Politti U, Giuggioli D, Ferri C, Antonelli A. Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection. Int J Endocrinol 2014;2014:935131. [PMID: 25374602 DOI: 10.1155/2014/935131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
9 Kleefeld F, Arendt G, Neuen-Jacob E, Maschke M, Husstedt I, Obermann M, Schmidt H, Hahn K; Deutsche Gesellschaft für Neuro-AIDS und Neuro-Infektiologie (DGNANI). [Neurological complications of hepatitis C infections]. Nervenarzt 2021;92:144-9. [PMID: 33001263 DOI: 10.1007/s00115-020-00999-6] [Reference Citation Analysis]
10 Antonelli A, Ferrari SM, Giuggioli D, Di Domenicantonio A, Ruffilli I, Corrado A, Fabiani S, Marchi S, Ferri C, Ferrannini E, Fallahi P. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes 2014; 5(5): 586-600 [PMID: 25317237 DOI: 10.4239/wjd.v5.i5.586] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
11 Pastore F, Martocchia A, Stefanelli M, Prunas P, Giordano S, Toussan L, Devito A, Falaschi P. Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment. World J Hepatol 2016; 8(2): 83-91 [PMID: 26807204 DOI: 10.4254/wjh.v8.i2.83] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
12 Antonelli A, Ferrari SM, Ruffilli I, Fallahi P. Cytokines and HCV-related autoimmune disorders. Immunol Res. 2014;60:311-319. [PMID: 25381483 DOI: 10.1007/s12026-014-8569-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
13 Conca P, Tarantino G. Hepatitis C virus lymphotropism and peculiar immunological phenotype: Effects on natural history and antiviral therapy. World J Gastroenterol 2009; 15(19): 2305-2308 [PMID: 19452570 DOI: 10.3748/wjg.15.2305] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
14 Alaarag AF, Hamam AM, Amin OA. The Safety of The Directly Acting Antiviral Treatment For Hepatitis C Virus According To The Egyptian National Program Protocol In Patients With Midrange Ejection Fraction. Glob Heart 2021;16:3. [PMID: 33598383 DOI: 10.5334/gh.906] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rotman Y, Liang TJ. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol. 2009;83:7366-7374. [PMID: 19420073 DOI: 10.1128/jvi.00191-09] [Cited by in Crossref: 89] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
16 Hoffman GS, Calabrese LH. Vasculitis: determinants of disease patterns. Nat Rev Rheumatol 2014;10:454-62. [PMID: 24934189 DOI: 10.1038/nrrheum.2014.89] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
17 Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I. Hepatitis C virus and neurological damage. World J Hepatol 2016; 8(12): 545-556 [PMID: 27134702 DOI: 10.4254/wjh.v8.i12.545] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
18 Pasquet F, Combarnous F, Macgregor B, Coppere B, Mausservey C, Ninet J, Hot A. Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report. J Med Case Rep. 2012;6:39. [PMID: 22284897 DOI: 10.1186/1752-1947-6-39] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
19 Mirabella M, Taramasso L, Nicolini LA, Russo R, Viscoli C, Di Biagio A. Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature. Clin Nephrol Case Stud 2018;6:31-5. [PMID: 30406000 DOI: 10.5414/CNCS109221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Himoto T, Masaki T. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol 2012;2012:871401. [PMID: 22988469 DOI: 10.1155/2012/871401] [Reference Citation Analysis]
21 Bunchorntavakul C, Maneerattanaporn M, Chavalitdhamrong D. Management of patients with hepatitis C infection and renal disease. World J Hepatol 2015; 7(2): 213-225 [PMID: 25729476 DOI: 10.4254/wjh.v7.i2.213] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
22 Bunchorntavakul C, Chavalitdhamrong D, Tanwandee T. Hepatitis C genotype 6: A concise review and response-guided therapy proposal. World J Hepatol 2013; 5(9): 496-504 [PMID: 24073301 DOI: 10.4254/wjh.v5.i9.496] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
23 Formentin C, Garrido M, Montagnese S. Assessment and Management of Sleep Disturbance in Cirrhosis. Curr Hepatol Rep 2018;17:52-69. [PMID: 29876197 DOI: 10.1007/s11901-018-0390-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
24 Monaco S, Mariotto S, Ferrari S, Calabrese M, Zanusso G, Gajofatto A, Sansonno D, Dammacco F. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World J Gastroenterol 2015; 21(42): 11974-11983 [PMID: 26576086 DOI: 10.3748/wjg.v21.i42.11974] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 48] [Article Influence: 8.4] [Reference Citation Analysis]
25 Vena A, Bouza E, Bassetti M, Menichetti F, Merelli M, Grau S, Fortun J, Sánchez MI, Aguado JM, Merino P, Bonache F, Muñoz P. Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child-Pugh B or C Liver Disease: A Case-Control Retrospective Study. Infect Dis Ther 2020;9:151-63. [PMID: 32086777 DOI: 10.1007/s40121-020-00282-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ferri C, Colaci M, Fallahi P, Ferrari SM, Antonelli A, Giuggioli D. Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia. Front Endocrinol (Lausanne) 2017;8:159. [PMID: 28736547 DOI: 10.3389/fendo.2017.00159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
27 Himoto T, Masaki T. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol 2012;2012:871401. [PMID: 22988469 DOI: 10.1155/2012/871401] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
28 Isaacs D, Abdelaziz N, Keller M, Tibble J, Haq I. Measuring the response of extrahepatic symptoms and quality of life to antiviral treatment in patients with hepatitis C. Hepat Res Treat 2013;2013:910519. [PMID: 24223303 DOI: 10.1155/2013/910519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Himoto T, Masaki T. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol. 2012;2012:871401. [PMID: 22988469 DOI: 10.1155/2012/871401].] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Ferri C, Sebastiani M, Antonelli A, Colaci M, Manfredi A, Giuggioli D. Current treatment of hepatitis C-associated rheumatic diseases. Arthritis Res Ther. 2012;14:215. [PMID: 22731694 DOI: 10.1186/ar3865] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
31 Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J 2009;6:5. [PMID: 19138419 DOI: 10.1186/1743-422X-6-5] [Cited by in Crossref: 177] [Cited by in F6Publishing: 80] [Article Influence: 13.6] [Reference Citation Analysis]
32 Bergonzini V, Salata C, Calistri A, Parolin C, Palù G. View and review on viral oncology research. Infect Agent Cancer 2010;5:11. [PMID: 20497566 DOI: 10.1186/1750-9378-5-11] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
33 Petti S, Rabiei M, De Luca M, Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology 2011;99:168-78. [PMID: 21505737 DOI: 10.1007/s10266-011-0008-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]